as 07-26-2024 4:00pm EST
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in 4 divisions: Sterilization and Disinfection Control, which manufactures and sells biological, cleaning, and chemical indicators. It also provides testing and laboratory services, mainly to the dental industry; Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions; Calibration Solutions division develops, manufactures, and sells quality control and calibration products used to measure or calibrate temperature, pressure, pH, humidity, and other such parameters for health and safety purposes; and Clinical Genomics. Its geographical segments include United States and Foreign.
Founded: | 1982 | Country: | United States |
Employees: | N/A | City: | LAKEWOOD |
Market Cap: | 494.6M | IPO Year: | N/A |
Target Price: | $106.00 | AVG Volume (30 days): | 49.0K |
Analyst Decision: | Buy | Number of Analysts: | 1 |
Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
EPS: | -47.20 | EPS Growth: | N/A |
52 Week Low/High: | $82.86 - $145.46 | Next Earning Date: | 08-05-2024 |
Revenue: | $216,187,000 | Revenue Growth: | -1.32% |
Revenue Growth (this year): | 10.4% | Revenue Growth (next year): | 6.62% |
Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Archbold Brian David | MLAB | SVP Operations | Dec 15 '23 | Sell | $112.36 | 1,500 | $168,540.00 | 558 | SEC Form 4 |
MLAB Breaking Stock News: Dive into MLAB Ticker-Specific Updates for Smart Investing
Argus Research
3 days ago
Argus Research
10 days ago
Argus Research
17 days ago
GlobeNewswire
18 days ago
GOBankingRates
2 months ago
AFP
2 months ago
AFP
2 months ago
AFP
2 months ago
The information presented on this page, "MLAB Mesa Laboratories Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.